Skip to search.
 FTSE 100 Up 0.33%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
32.66 Down 1.83(5.31%) 9 Dec 21:00
Prev Close:34.49
Open:34.81
Bid:32.25 x 200
Ask:32.65 x 100
1y Target Est:71.50
Beta:2.0131
Earnings Date:23 Feb - 27 Feb (Est.)
Day's Range:32.59 - 35.38
52wk Range:8.00 - 63.73
Volume:2,013,881
Avg Vol (3m):4,413,260
Market Cap:1.78b
P/E (ttm):N/A
EPS (ttm):-5.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SRPTDown 5.31%1.78b
GSKUp 1.07%90.05b
ALNYUp 3.54%3.63b
ISIS 0.00%0.00

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,502,641.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-4.70
Quarterly EPS Est (Dec-16) :-0.91
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):36.70

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback